Figure S1. Optimization of lacrimal gland stem cell medium (LGSCM). A. The morphology of primary cultured LGSCs at day 7 in the LGSCM and withdrawing of EGF, FGF10, Wnt3A, and Y-27632, respectively. B. The diameter of primary cultured LGSCs at day 7 in the LGSCM and withdrawing of EGF, FGF10, Wnt3A, and Y-27632, respectively. C. The cell numbers of primary cultured LGSCs at day 7 in the LGSCM and withdrawing of EGF, FGF10, Wnt3A, and Y-27632, respectively. D. The morphology of passaged LGSCs at day 7 in the LGSCM and withdrawing of Wnt3A. E. The diameter of passaged LGSCs at day 7 in the LGSCM and withdrawing of Wnt3A. F. The cell numbers of passaged
